ArticleMolecular plant pathology2025
A Cotton Laccase Confers Disease Resistance Against Verticillium dahliae by Promoting Cell Wall Lignification.
Article in Molecular plant pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- GhCOR27 confers Verticillium wilt resistance in cotton by relieving the GhASIL1-GhERF114-mediated repression of lignin accumulation.Plant physiology · 2026Article
- The GhWRKY70-International journal of molecular sciences · 2026Article
- Article
- Genome-Wide Identification Analysis of the MAPKKK Gene Family in Cotton and Its Role in Development and Stress Response.International journal of molecular sciences · 2026Article
- The laccase geneFrontiers in plant science · 2026Article
- Anisotropic boundary-aware detection for cotton leaf diseases with boundary-decoupled regression and lightweight feature adaptation.Frontiers in plant science · 2026Article
- A Cotton Laccase Confers Disease Resistance Against Verticillium dahliae by Promoting Cell Wall Lignification.Molecular plant pathology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Verticillium wilt (VW), caused primarily by Verticillium dahliae, is a significant threat to cotton production. Lignification of the plant cell wall, a defence response triggered by pathogen invasion, is critical for plant resistance to numerous diseases. Laccases are known to participate in the lignification of secondary cell walls, but their role in cotton resistance to V. dahliae is not fully understood. In this study, we identified a cotton laccase gene, GhLAC14-3, that was significantly upregulated during early V. dahliae infection and was closely related to a gene previously reported to respond to V. dahliae infection in Arabidopsis. Silencing of GhLAC14-3 in cotton increased disease susceptibility and reduced lignin deposition and the expression of lignin-related genes. By contrast, overexpression of GhLAC14-3 in transgenic Arabidopsis increased lignin content and the expression of lignin-related genes, thereby enhancing VW resistance. We identified an interaction between GhLAC14-3 and the mitogen-activated protein kinase GhMAPKKK2 at the cell membrane. GhMAPKKK2 expression was also significantly induced by V. dahliae infection in cotton, and its overexpression in Arabidopsis activated multiple key resistance genes, thus improving V. dahliae resistance. Transient co-expression of GhMAPKKK2 and GhLAC14-3 in Nicotiana benthamiana leaves significantly increased lignin content. Conversely, silencing of AtMAPKKK2, the homologue of GhMAPKKK2, in GhLAC14-3-overexpressing Arabidopsis reduced both lignin levels and disease resistance. Our findings suggest that GhLAC14-3 is a promising target for enhancing VW resistance, as its interaction with GhMAPKKK2 at the cell membrane modulates defence-induced lignification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.